Results 201 to 210 of about 63,420 (248)

From clinics to sewers: leveraging environmental surveillance and whole genome sequencing to inform transmission of ESBL-<i>Escherichia coli</i> in Switzerland. [PDF]

Appl Environ Microbiol
Conforti S, du Plessis L, Bagutti C, Becker J, Brugger SD, Cusini A, Egli A, Gaia V, Greub G, Guler C, Huisman JS, Kocher C, Kouyos RD, Leuzinger K, Maffioli C, Neacșu M, Nolte O, Ramette A, Seiffert SN, Tschudin-Sutter S, Zumthor JP, Stadler T, Julian TR.   +22 more
europepmc   +1 more source

Trends and correlations of infection rates and drug resistance of Escherichia coli among ICU and Non-ICU patients in Guizhou, China. [PDF]

PLoS One
Dong Z, Mu X, Du W, An Z, Xiang J, Yang A, Li Q, Chen Z.   +7 more
europepmc   +1 more source

[ESBL – risk factors and treatment].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 2016
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Characterization of ESBL disseminating plasmids

Infectious Diseases, 2015
Bacteria producing extended-spectrum β-lactamases (ESBLs) constitute a globally increasing problem that contributes to treatment complications and elevated death rates. The extremely successful dissemination by ESBL-producing Enterobacteriaceae during the latest decades is a result of the combination of mobilization, evolution and horizontal spread of ...
Alma, Brolund, Linus, Sandegren
openaire   +2 more sources

Detection of extended-spectrum beta-lactamase (ESBL)-producing strains by the Etest ESBL screen

Journal of Clinical Microbiology, 1996
Resistance to contemporary broad-spectrum beta-lactams, mediated by extended-spectrum beta-lactamase (ESBL) enzymes, is an increasing problem worldwide. The Etest (AB Biodisk, Solna, Sweden) ESBL screen uses stable gradient technology to evaluate the MIC of ceftazidime alone compared with the MIC of ceftazidime with clavulanic acid (2 micrograms/ml) to
M G, Cormican, S A, Marshall, R N, Jones
openaire   +2 more sources

Cefepime pharmacodynamics in patients with extended spectrum β-lactamase (ESBL) and non-ESBL infections

Journal of Infection, 2007
This study was designed to compare cefepime exposures with microbiological outcomes in ESBL and non-ESBL infections and determine the pharmacodynamic profiles associated with successful outcome.Cefepime pharmacodynamic exposures of unbound drug [time above MIC (fT>MIC), minimal concentration over MIC (fC(min)/MIC), and area under the curve over MIC ...
Su Young, Lee, Joseph L, Kuti, David P, Nicolau   +2 more
openaire   +2 more sources

ESBL-colonization at ICU admission: impact on subsequent infection, carbapenem-consumption, and outcome

Infection control and hospital epidemiology, 2019
Objective: To determine whether colonization with extended-spectrum β-lactamase–producing Enterobacteriaceae (ESBL-PE) predicts the risk for subsequent infection and impacts carbapenem-consumption and outcome in intensive care unit (ICU) patients. Design:
A. Martinez, A. Widmer, R. Frei, H. Pargger, D. Tuchscherer, S. Marsch, A. Egli, S. Tschudin-Sutter   +7 more
semanticscholar   +1 more source